top of page

Search


Alpha Lipoic Acid and Healthy Aging
Alpha lipoic acid supports mitochondrial energy production, improves insulin sensitivity, and protects vascular and nerve health. This physician-to-patient guide explains how ALA may support disease prevention and healthy aging when used within a comprehensive longevity strategy.

David Stephen Klein, MD FACA FACPM
Mar 274 min read


What Is an Antioxidant—and Why Are Antioxidants Important?
Antioxidants are essential biological protectors that help maintain cellular integrity by neutralizing harmful molecules known as free radicals. Free radicals are produced naturally during metabolism and play limited roles in immune defense and cell signaling. However, when their production exceeds the body’s protective capacity—a state known as oxidative stress—they can damage cell membranes, proteins, mitochondria, and DNA. Over time, this damage contributes to aging and ma

David S. Klein, MD FACA FACPM
Mar 246 min read


DiAcCA (Di-Acetylated Carnosic Acid): A Precision Neuroprotective Strategy Targeting Oxidative Stress
Di-acetylated carnosic acid (DiAcCA) is a rosemary-derived investigational compound designed to activate the Nrf2 antioxidant pathway selectively in oxidatively stressed brain tissue. Rather than acting as a simple antioxidant, it amplifies intrinsic cellular defense systems. Preclinical data suggest potential applications in Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury, though human trials remain limited.

David Stephen Klein, MD FACA FACPM
Mar 133 min read


Atherogenic Dyslipidemia: Why Triglycerides and HDL Matter More Than LDL Alone
Atherogenic dyslipidemia—marked by high triglycerides, low HDL, and small dense LDL—often hides behind normal LDL cholesterol. This insulin-resistant lipid pattern predicts cardiovascular disease earlier and more accurately than LDL alone.

David S. Klein, MD FACA FACPM
Feb 243 min read


Fatty Liver Disease (MASLD): The Metabolic Warning Sign of Insulin Resistance
Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly called fatty liver, is not a liver problem alone—it is a systemic marker of insulin resistance. Often silent for years, MASLD signals elevated cardiometabolic, cognitive, and longevity risk long before abnormal liver enzymes or diabetes appear.

David S. Klein, MD FACA FACPM
Feb 173 min read


Hyperinsulinemia: The Metabolic Condition We Rarely Diagnose- but Routinely Treat Too Late
Hyperinsulinemia often precedes diabetes by decades, quietly driving heart disease, weight gain, hypertension, fatty liver disease, and accelerated aging—even when glucose levels appear normal. Early detection shifts care from reactive treatment to true prevention.

David S. Klein, MD FACA FACPM
Feb 134 min read


Essential Vitamins and Supplements for Liver Health: Managing Fatty Liver Disease MASLD
Managing fatty liver disease MASLD requires a comprehensive approach. Vitamins and supplements can support liver health by reducing oxidative stress, improving metabolism, and lowering inflammation. However, they are part of a broader strategy that includes diet, exercise, and medical care.

David S. Klein, MD FACA FACPM
Dec 11, 20255 min read


Peptide therapy: promise, pitfalls and what patients should know
Peptides are short amino-acid chains that act as highly specific signaling molecules and have become a major class of modern therapeutics. More than 80 peptide drugs are approved worldwide, including insulin, incretin analogues such as GLP-1 receptor agonists, vasopressin analogues and linaclotide. These agents provide effective, targeted therapy in endocrine, metabolic, gastrointestinal and oncologic indications, supported by robust randomized clinical trials and rigorous ma

David S. Klein, MD FACA FACPM
Dec 5, 20258 min read


Have a Happy Holiday: Detox Essentials
Detoxification is often misunderstood as a fad, yet it remains a central physiological process essential for human survival. The holiday season—marked by stress, alcohol consumption, disrupted sleep, and poor dietary choices—places a substantial metabolic burden on the liver, gallbladder, kidneys, lungs, and intestinal tract. This blog outlines the science behind the body’s three-phase detox pathway and explains how targeted nutritional support can enhance natural clearance m

David S. Klein, MD FACA FACPM
Dec 2, 202510 min read


The Link Between Fructose Beverages and Non-Alcoholic Fatty Liver Disease
Understanding the connection between fructose-containing beverages and fatty liver disease empowers people to make informed choices. By reducing sugary drink intake and adopting healthier habits, it is possible to protect the liver and improve overall health.

David S. Klein, MD FACA FACPM
Nov 10, 20255 min read
bottom of page
